Bibliographic Details
| Title: |
Platelet transfusions in adult thrombocytopenic ICU patients: Protocol for a sub‐study of the PLOT‐ICU cohort. |
| Authors: |
Anthon, Carl Thomas1 (AUTHOR) carl.anthon@gmail.com, Pène, Frédéric2 (AUTHOR), Perner, Anders1,3,4 (AUTHOR), Azoulay, Elie4 (AUTHOR), Puxty, Kathryn5 (AUTHOR), Van De Louw, Andry6 (AUTHOR), Chawla, Sanjay7,8 (AUTHOR), Castro, Pedro9 (AUTHOR), Povoa, Pedro10,11,12 (AUTHOR), Coelho, Luis10,11 (AUTHOR), Metaxa, Victoria13 (AUTHOR), Kochanek, Matthias14 (AUTHOR), Liebregts, Tobias15 (AUTHOR), Kander, Thomas16,17 (AUTHOR), Sivula, Mirka18,19 (AUTHOR), Møller, Morten Hylander1,3 (AUTHOR), Russell, Lene1,3,4 (AUTHOR) |
| Source: |
Acta Anaesthesiologica Scandinavica. Mar2024, Vol. 68 Issue 3, p434-440. 7p. |
| Subject Terms: |
*BLOOD platelet transfusion, *BLOOD transfusion, *INTENSIVE care units, *PLATELET count, *ADULTS |
| Abstract: |
Introduction: Platelet transfusions are frequently used in intensive care unit (ICU) patients, but contemporary epidemiological data are sparse. We aim to present contemporary international data on the use of platelet transfusions in adult ICU patients with thrombocytopenia. Methods: This is a protocol and statistical analysis plan for a post hoc sub‐study of 504 thrombocytopenic patients from the 'Thrombocytopenia and platelet transfusions in ICU patients: an international inception cohort study (PLOT‐ICU)'. The primary outcome will be the number of patients receiving platelet transfusion in the ICU reported according to the type of product received (apheresis‐derived versus pooled whole‐blood‐derived transfusions). Secondary platelet transfusion outcomes will include platelet transfusion volumes; timing of platelet transfusion; approach to platelet transfusion dosing (fixed dosing versus weight‐based dosing) and platelet count increments for prophylactic transfusions. Secondary clinical outcomes will include the number of patients receiving red blood cell‐ and plasma transfusions during ICU stay; the number of patients who bled in the ICU, the number of patients who had a new thrombosis in the ICU, and the number of patients who died. The duration of follow‐up was 90 days. Baseline characteristics and secondary clinical outcomes will be stratified according to platelet transfusion status in the ICU and severity of thrombocytopenia. Data will be presented descriptively. Conclusions: The outlined study will provide detailed epidemiological data on the use of platelet transfusions in adult ICU patients with thrombocytopenia using data from the large international PLOT‐ICU cohort study. The findings will inform the design of future randomised trials evaluating platelet transfusions in ICU patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of Acta Anaesthesiologica Scandinavica is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
